
Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Stock Performance (90 Days)
Layoff History
Recent News
Other Biotechnology Companies
View All →Frequently Asked Questions
Has Whitehawk Therapeutics, Inc. had layoffs?
How many employees does Whitehawk Therapeutics, Inc. have?
What industry is Whitehawk Therapeutics, Inc. in?
Is Whitehawk Therapeutics, Inc. a publicly traded company?
Where is Whitehawk Therapeutics, Inc. headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.